Iowa Senators Approve Psilocybin Therapy Bill For PTSD Patients

An Iowa Senate panel has approved a House-passed bill to create a
state-regulated therapeutic psilocybin program for patients with
post-traumatic stress disorder (PTSD).

The Senate Health and Human Services Committee advance the legislation from
Rep. John Wills (R) in a voice vote on Thursday.

The panel adopted an amendment from Sen. Dennis Guth (R) to narrow the
scope of the bill to allow only people with PTSD to access the psychedelic
therapy instead of the broader version that was passed by the House last
year.

The revised measure also eliminates provisions that would have created a
new Psilocybin Production Establishment Licensing Board under the Iowa
Department of Health and Human Services (HHS) to oversee the industry.
Instead, the current Medical Cannabidiol Advisory Board would take on the
responsibility of regulating the psychedelic and be renamed to the Medical
Controlled Substance Advisory and Licensing Board.

“I have some friends, some people I know, that I think would really benefit
from this,” Guth said. “But we have to be careful how we proceed with this.”

Sen. Kara Warme (R), the chair of the panel, agreed, saying that the “bill
is not done” and still needs some more work before it should be enacted
into law.

“I think we have an interesting challenge as lawmakers to look at a really
promising potential solution to help Iowans with PTSD, especially our
veterans, who are facing this—but also there is a lot of unknowns that
remain,” she said. “It’s a new potential solution, and so I appreciate the
work that’s going in to make sure that we do this in the right way that’s
cost effective for tax taxpayers, and also thinks through the risks and
rewards of something new and not heavily studied like this.”

If enacted into law, HF 978 would allow patients with PTSD who receive
recommendations from medical professionals to legally access psilocybin
produced in-state by licensed entities. Administration sessions for the
psychedelic would be supervised by registered facilitators who would need
to complete state-specified psilocybin education.

Administration sessions themselves would need to take place at registered
clinical locations and would need to be video recorded. Those records would
need to be available for inspection by state officials upon request.

Local governments could not outright ban psilocybin facilities, nor could
they deny them appropriate licenses based merely on the fact that the
psychedelic is federally illegal.

Notably, a licensed psilocybin production facility could be co-located with
one of the state’s few licensed medical cannabis producers—known in Iowa as
medical cannabidiol producers—and the bill says regulators may grant
psilocybin licensing preferences to those existing cannabis producers.
Facilities couldn’t be located within 1,000 feet of a community location or
500 feet of a residential area.

Only people 21 and older and who do not have a misdemeanor for drug
distribution or any felony on their record could work at psilocybin
producers, and licensees themselves would face background checks.

Up to four independent testing labs could be licensed under the bill, and
the state could also establish its own lab.

License applications would be accepted beginning July 1, 2026.

The measure also directs HHS to conduct a study on “the use of psychedelic
compounds other than psilocybin in the treatment of medical conditions.”


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

The bill as originally introduced would have limited the psilocybin therapy
program only to patients with PTSD, with a ceiling of 5,000 participants at
any one time, but those provisions were removed with a House floor
amendment last year. Now, however, the Senate panel has added back in the
limitation to PTSD patients only.

Last year, Gov. Kim Reynolds (R) vetoed separate legislation that would
have allowed doctors in the state to immediately prescribe a synthetic form
of psilocybin in the event of federal approval of the psychedelic substance
by the U.S. Food and Drug Administration (FDA), arguing that it “surrenders
state authority to make an informed determination about classification to
federal officials.”

“This decision is not a dismissal of the emerging science or the sincere
advocacy behind this legislation,” the governor said at the time. “Rather,
it is a call for a more deliberate and Iowa-centric approach.”

*Image courtesy of CostaPPR.*

The post Iowa Senators Approve Psilocybin Therapy Bill For PTSD Patients
appeared first on Marijuana Moment.